Antidepressants and Kids
A new review concludes that the benefits of antidepressant medications for children and teens appear to be much greater than the risks.
Partnership for Prescription Assistance
A new toll-free number and Web site provide help to those who lack prescription coverage or cannot afford their medications.
FDA Requires "Black Box" Warning on Antidepressants
NAMI applauds the FDA for calling for close monitoring of youth living with depression and for providing better information about medications for treating depression in youth. However, the FDA's actions may also have unintended negative consequences.
Treating Kids with Depression
New FDA warnings about the use of anti-depressant medications for children leave parents, caregivers wondering about options.
NAMI Urges the FDA to Promptly Issue Guidance on the Use of SSRIs to Treat Major Depression in Children
NAMI calls on the U.S. Food and Drug Administration (FDA) to provide clear guidance to families and mental health providers on the safe and effective treatment of major depression in children--after reviewing all of the relevant research data.
Prescription Drug Patient Assistance Programs
Some pharmaceutical companies offer medication assistance programs to low-income individuals and families. This chart includes most psychotropic medications covered by such programs, as well as contact information for the pharmaceutical companies.
Living with Major Depression
Welcome to NAMI's Living with Major Depression community. Here you will find support, get targeted information and connect with people who understand.